Morepen Laboratories Ltd share price logo

Morepen Laboratories Share Price

NSE: MOREPENLAB

BSE: 500288

Small Cap

Healthcare Sector

₹38.06

-1.17

(-2.98%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Morepen Laboratories Stock Performance

as on February 5, 2026 at 12:00 pm IST

  • Day's Low

    Day's High

    ₹37.85
    ₹39.38
    downward going graph

    0.55%

    Downside

    3.47%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹33.50
    ₹70.50
    downward going graph

    11.98%

    Downside

    85.23%

    Upside

    downward going graph

Morepen Laboratories share price movements today

Previous Close
₹39.23
Open
₹38.14
Volume
8.81L
Upper Circuit
₹47.07
Lower Circuit
₹31.39
Day's Low - High
₹37.85 - ₹39.38
52 Week Low - High
₹33.50 - ₹70.50

Morepen Laboratories Historical Returns

1 Month Return
-4.92 %
3 Month Return
-17.36 %
1 Year Return
-41.17 %
3 Year Return
+ 38.62 %
5 Year Return
+ 33.44 %

Morepen Laboratories Fundamentals

as on February 5, 2026 at 12:00 pm IST

Market Cap

₹2,149.62 Cr

Return on Equity (ROE)

9.81

PE Ratio (TTM)

21.92

Return on capital employed (ROCE)

12.79

Industry PE ratio

41.03

Beta (LTM)

1.78

P/B Ratio

2.22

Dividend Yield

0.42

PEG Ratio

-29.62

Quarterly Earnings Growth YOY

17.76

EPS (TTM)

2.15

Sector

Pharmaceuticals

Book Value

21.1

Technical Analysis

Neutral

View Technical Analysis

Morepen Laboratories Stock Valuation

as on February 5, 2026 at 12:00 pm IST

Morepen Laboratories in the last 5 years

  • Overview

  • Trends

Lowest (10.48x)

March 23, 2020

Today (21.92x)

February 4, 2026

Industry (41.03x)

February 4, 2026

Highest (64.70x)

January 22, 2018

LowHigh

Today’s Price to Earnings Ratio: 21.92x

Morepen Laboratories Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Morepen Laboratories with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Morepen Laboratories Ltd image
Morepen Laboratories Ltd
NA2,149.626.69%0.571181,811
Bharat Parenterals Ltd image
Bharat Parenterals Ltd
NA644.9528.85%0.69-44340
Astonea Labs Ltd image
Astonea Labs Ltd
NA161.872.71%0.00597
Emcure Pharmaceuticals Ltd image
Emcure Pharmaceuticals Ltd
BUY29,097.492.59%0.637077,896
Chandra Bhagat Pharma Ltd image
Chandra Bhagat Pharma Ltd
NA31.84-2.04%0.00186
See all

Morepen Laboratories Share Price Target

Get share price movements and forecasts by analysts on Morepen Laboratories.

Source: S&P Global Market Intelligence

Morepen Laboratories Stock’s Investor Sentiment and Interest

Investment in Morepen Laboratories Ltd Shares on INDmoney has dropped by -17.22% over the past 30 days, indicating reduced transactional activity.

Time period: to

Change:-17.22% versus previous 30 day period

Morepen Laboratories Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Sales
363.69
401.04
421.77
444.55
423.07
455.22
437.73
452.78
465.85
425.24
411.58
Other Income
3.12
2.42
3.24
4.07
4.24
3.43
4.99
5.34
4.61
4.41
30.46
Total Income
366.81
403.46
425.01
448.62
427.32
458.64
442.71
458.12
470.46
429.65
442.04
Expenses
348.13
374.95
388.18
393.99
374.69
403.6
393.66
416.64
423.61
401.07
380.88
Operating Profit
15.56
26.09
33.59
50.56
48.38
51.62
44.07
36.14
42.24
24.17
30.7
Operating Profit Margin %
4.28%
6.51%
7.96%
11.37%
11.44%
11.34%
10.07%
7.98%
9.07%
5.68%
7.46%
Profit Before Interest, Tax and Depreciation
18.68
28.51
36.83
54.64
52.62
55.05
49.06
41.48
46.85
28.58
61.16
Interest
0.56
0.28
0.46
2.17
0.8
1.15
1.18
1.34
4.67
4.04
4.18
Depreciation
6.98
7.71
7.69
8.45
9.62
5.73
1.86
4.93
16.47
9.03
11.28
Profit Before Tax
11.14
20.52
28.68
44.02
42.2
48.17
46.02
35.21
25.71
15.51
45.7
Tax Paid
2.9
5.88
7.43
12.03
13.46
12
11.17
8.52
5.41
4.11
4.65
Profit After Tax
8.24
14.63
21.26
31.99
28.74
36.17
34.85
26.69
20.31
11.41
41.04
Total Net profit including share of profit / Loss from associate company
8.24
14.63
21.26
31.99
28.74
36.17
34.85
26.69
20.31
11.41
41.04
EPS
0.16
0.29
0.42
0.63
0.54
0.71
0.65
0.49
0.35
0.2
0.75
Actual EPS
0.16
0.29
0.42
0.63
0.54
0.71
0.65
0.49
0.35
0.2
0.75
Adjusted EPS
0.16
0.29
0.42
0.63
0.54
0.71
0.65
0.49
0.35
0.2
0.75
Diluted EPS
0.16
0.29
0.42
0.63
0.54
0.71
0.65
0.49
0.35
0.2
0.75

Morepen Laboratories Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Sales
595.47
606.51
768.54
853.07
1,188.06
1,546.83
1,417.53
1,690.43
1,811.58
Other Income
3.72
3.72
3.67
9.48
12.07
10.31
6.13
13.97
18.36
Total Income
599.19
610.23
772.21
862.55
1,200.13
1,557.13
1,423.66
1,704.4
1,829.94
Expenses
534.09
541.96
701.02
784.55
1,069.54
1,410.15
1,338
1,531.81
1,637.51
Operating Profit
61.38
64.55
67.52
68.52
118.52
136.68
79.53
158.62
174.07
Operating Profit Margin %
10.31%
10.64%
8.79%
8.03%
9.98%
8.84%
5.61%
9.38%
9.61%
Profit Before Interest, Tax and Depreciation
65.1
68.27
71.19
78
130.58
146.98
85.67
172.6
192.43
Interest
7.56
4.36
2.11
1.98
1.79
-7.37
1.98
3.71
8.34
Depreciation
33.9
34.32
39.9
36.91
30.28
27.64
27.93
33.47
28.98
Profit Before Tax
23.64
29.59
29.18
39.11
98.51
126.71
55.76
135.42
155.11
Tax Paid
-
-
0.34
5.53
1.42
25.02
17.08
38.79
37.1
Profit After Tax
23.63
29.59
28.84
33.58
97.09
101.68
38.68
96.62
118.02
Total Net profit including share of profit / Loss from associate company
23.63
29.59
28.84
33.58
97.09
101.68
38.68
96.62
118.02
EPS
0.52
0.66
0.64
0.75
2.16
2.26
0.77
1.88
2.2
Actual EPS
0.52
0.66
0.64
0.75
2.16
2.26
0.77
1.88
2.2
Adjusted EPS
0.52
0.66
0.64
0.75
2.16
2.26
0.77
1.88
2.2
Diluted EPS
0.52
0.66
0.64
0.75
2.15
1.96
0.77
1.88
2.2

Morepen Laboratories Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
50.07
40.73
63.41
17.37
11.02
50.83
-60.24
-91.17
73.37
32.06
Cash Flow from Investing Activities
-27.3
-13.6
-26.92
-13.05
-12.46
-70.35
-31.68
-46.51
-83.31
-321.51
Cash Flow from Financing Activities
-27.26
-23.72
-37.78
-0.44
5.49
47.26
66.33
143.54
5.2
299.89
Net Cash Flow
-4.49
3.4
-1.29
3.88
4.04
27.75
-25.58
5.86
-4.72
10.44

Morepen Laboratories Stock Shareholding Pattern

Numbers in percentages

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Aug 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Promoters
38.22%
38.22%
38.22%
38.22%
38.22%
38.22%
35.65%
35.65%
35.65%
35.65%
35.65%
35.65%
35.65%
DII
2.93%
2.33%
2.28%
2%
2.15%
2.15%
2.9%
1.7%
1.64%
1.68%
1.51%
1.5%
1.25%
FII
0%
0%
1.29%
0%
1.85%
1.67%
7.72%
2.08%
2.22%
1.94%
1.72%
1.62%
1.62%
Government
0.01%
0.01%
0.01%
0.01%
0.01%
0.01%
0.01%
0.01%
0.01%
0.01%
0.01%
0.01%
0.01%
Public
57.88%
58.44%
58.2%
57.44%
57.77%
57.95%
53.72%
60.56%
60.47%
60.72%
61.11%
61.21%
61.46%
Total Outstanding Shares
51,11,68,708
51,11,68,708
51,11,68,708
51,11,68,708
51,11,68,708
51,11,68,708
54,79,53,699
54,79,53,699
54,79,53,699
54,79,53,699
54,79,53,699
54,79,53,699
54,79,53,699
Total Shareholders
3,06,150
3,01,832
3,04,001
3,04,289
3,36,019
3,48,766
3,52,839
4,30,929
4,48,361
4,68,860
4,61,180
4,61,853
4,53,137

Mutual Funds that own Morepen Laboratories Stock

Check out the Mutual Funds with significant holdings in Morepen Laboratories.

Morepen Laboratories Corporate Actions

View detailed summary of the earnings and dividend history of Morepen Laboratories.

  • Morepen Laboratories Ltd Earnings Results

    Morepen Laboratories Ltd’s net profit jumped 17.27% since last year same period to ₹40.87Cr in the Q2 2025-2026. On a quarterly growth basis, Morepen Laboratories Ltd has generated 280.19% jump in its net profits since last 3-months.

    Read More about Earnings Results

  • Morepen Laboratories Ltd Dividends May,2025

    In the quarter ending March 2025, Morepen Laboratories Ltd has declared dividend of ₹0.20 per share on 12 May 2025 - translating a dividend yield of 0.53%.

    Read More about Dividends

Indices Featuring Morepen Laboratories Stock

Check stock indices that include Morepen Laboratories.

BSE Healthcare

₹41,961.76

-0.55 (▲230.76%)

Insights on Morepen Laboratories Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 429.65 Cr → 442.04 Cr (in ₹), with an average increase of 2.8% per quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, 10.75 Cr → 40.87 Cr (in ₹), with an average increase of 73.7% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, MOREPENLAB stock has moved up by 11.6%

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 61.21% to 61.46% in Dec 2025 quarter

  • imgNO EFFECT

    FII Holding Unchanged

    img

    Foreign Institutions holdings remained unchanged at 1.62% of holdings in Dec 2025 quarter

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 35.65% of holdings in Dec 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Torrent Pharmaceuticals Ltd has given 29.2% return, outperforming this stock by 70.4%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 160.7% return, outperforming this stock by 122.0%

About Morepen Laboratories Ltd

Morepen Laboratories Limited is a pharmaceutical company based in India that develops and markets formulation products in numerous therapeutic categories, such as antibiotics, gastrointestinal, respiratory, analgesic, antiallergic, and neuropsychiatry. Their products include Loratadine Montelukast Sodium, Atorvastatin Calcium and Sultamicillin, along with new entries such as Kilbac Ducal, D Aclomore and Montelast-L. It currently has three state-of-the-art manufacturing plants in Himachal Pradesh, India, with the main plant in Parwanoo being USFDA-approved for Loratadine production. The company was established in 1984 and since then has filed 14 patents, including an international one on a new amorphous form of Lipitor Atorvastatin. Expansion plans from 1992-1993 saw the installation of bulk drugs from 162 MT to 245 MT and the launch of two new molecules – Ketrolac, Tromethamine and Omeprazole. In 1995-1996, the company increased bulk drug installation from 305 MT to 469 MT and launched Loratadine and Cisapride. The year 1996-1997 saw the commencement of their own formulation unit, while they filed an international patent on a new amorphous form of Atorvastatin, world’s largest selling drug in 2000-2001. In 2001-2002, their drug and drug intermediate installation reached 1251 MT, with the launch of a number of contemporary lifestyle and self-medication products. Their joint venture with DiaMed AG of Switzerland was among the highlights of the year 2004-2005, while 2006-2007 saw them acquire fifty new prospective customers in Korea, Japan and Taiwan. The year 2007-2008 was marked by the company making tie-ups with several new business segments, along with marketing alliances with global players such as Immucor USA, Teco Medical Instruments, and In-Tech, INC.

Revenue: ₹411.58Cr as on September 2025 (Q2 FY26)
Net Profit: ₹41.04Cr as on September 2025 (Q2 FY26)
Listing date: 15 May, 1995
Chairperson Name: Sushil Suri
OrganisationMorepen Laboratories Ltd
HeadquartersGurgaon
IndustryPharmaceuticals
CEOSushil Suri
E-voting on sharesClick here to vote

FAQs

What is Morepen Laboratories share price today?

Morepen Laboratories share price today stands at ₹38.06 as on . Morepen Laboratories share today touched a day high of ₹39.38 and a low of ₹37.85.

What is the 52 week high and 52 week low range for Morepen Laboratories share?

Morepen Laboratories touched a 52 week high of ₹70.5 and a 52 week low of ₹33.5. Morepen Laboratories share price today i.e. is trending at ₹38.06, which is -46.01% down from its 52 week high and 13.61% up from its 52 week low.

What is Morepen Laboratories's market capitalisation today?

Morepen Laboratories market capitalisation is ₹2,149.62 Cr as on .

How to buy Morepen Laboratories shares?

To buy Morepen Laboratories shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for MOREPENLAB or Morepen Laboratories Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Morepen Laboratories shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Morepen Laboratories trading volume today?

Morepen Laboratories trading volume is 8.81L as on . This means that 8.81L shares of Morepen Laboratories were bought and sold on the stock market during today's trading session.